Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies Meeting Abstract


Authors: Sznol, M.; Powderly, J. D.; Smith, D. C.; Brahmer, J. R.; Drake, C. G.; McDermott, D. F.; Lawrence, D. P.; Wolchok, J. D.; Topalian, S. L.; Lowy, I.
Abstract Title: Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 205s
Language: English
ACCESSION: WOS:000208852003098
DOI: 10.1200/jco.2010.28.15_suppl.2506
PROVIDER: wos
Notes: Meeting Abstract: 2506 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok